Secondary prevention of coronary heart disease in South Wales: a survey following myocardial infarction

• Published in: Heart (British Cardiac Society) Vol. 90; no. 11; pp. 1332 - 1333
• Main Authors: Underwood, P M, Cozma, L S, Laji, K, Cohen, H, Oboubie, K, Beck, P
• Format: Journal Article
• Language: English
• Published: London BMJ Publishing Group Ltd and British Cardiovascular Society 01.11.2004; BMJ; BMJ Publishing Group LTD; Copyright 2004 by Heart
• Subjects: ACE; Aged; angiotensin converting enzyme; Angiotensin-Converting Enzyme Inhibitors - therapeutic use; Anticoagulants - therapeutic use; Audit departments; Biological and medical sciences; Cardiology. Vascular system; Cardiovascular disease; CHD; Cholesterol - blood; Coronary Disease - complications; Coronary Disease - prevention & control; Coronary heart disease; Diabetes; diabetes mellitus; Disease prevention; Female; Glucose; Heart; Heart attacks; Heart failure; Hospitals; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; left ventricular failure; Lipids; Lipids - blood; LVF; Male; Medical sciences; Mortality; myocardial infarction; Myocardial Infarction - complications; Myocarditis. Cardiomyopathies; Platelet Aggregation Inhibitors - therapeutic use; Questionnaires; Rehabilitation; Risk Factors; Scientific Letters; secondary prevention; total cholesterol; Wales; United Kingdom; Great Britain; Europe; Wales; Myocardial infarction; Prevention; Survey; Secondary; Surveillance; Cardiovascular disease; Myocardial disease; Coronary heart disease
• ISSN: 1355-6037; 1468-201X
• DOI: 10.1136/hrt.2003.010942

Modification of vascular risk factors in such patients-secondary prevention-is particularly effective with evidence supporting use of antiplatelet agents, oral anticoagulants, β blockers, angiotensin converting enzyme (ACE) inhibitors, statins, and smoking cessation. According to the ECGs, 40% were inferior wall MIs, 34% anterior, 3% posterior, 4% left bundle branch block, and 19% indeterminate.